-
1دورية أكاديمية
المؤلفون: Motzer, Robert, Alekseev, Boris, Rha, Sun-Young, Porta, Camillo, Eto, Masatoshi, Powles, Thomas, Grünwald, Viktor, Hutson, Thomas E, Kopyltsov, Evgeny, Méndez-Vidal, María J, Kozlov, Vadim, Alyasova, Anna, Hong, Sung-Hoo, Kapoor, Anil, Alonso Gordoa, Teresa, Merchan, Jaime R, Winquist, Eric, Maroto, Pablo, Goh, Jeffrey C, Kim, Miso, Gurney, Howard, Patel, Vijay, Peer, Avivit, Procopio, Giuseppe, Takagi, Toshio, Melichar, Bohuslav, Rolland, Frederic, De Giorgi, Ugo, Wong, Shirley, Bedke, Jens, Schmidinger, Manuela, Dutcus, Corina E, Smith, Alan D, Dutta, Lea, Mody, Kalgi, Perini, Rodolfo F, Xing, Dongyuan, Choueiri, Toni K, CLEAR Trial Investigators
المساهمون: Gennigens, Christine
المصدر: New England Journal of Medicine, 384 (14), 1289 - 1300 (2021-04-08)
مصطلحات موضوعية: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Phenylurea Compounds, Programmed Cell Death 1 Receptor, Protein Kinase Inhibitors, Quinolines, Everolimus, pembrolizumab, lenvatinib, Sunitinib, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized/administration & dosage, Antibodies, Monoclonal, Humanized/adverse effects, Antineoplastic Agents/adverse effects, Antineoplastic Agents/therapeutic use, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Renal Cell/drug therapy, Carcinoma, Renal Cell/mortality, Everolimus/administration & dosage, Everolimus/adverse effects, Female, Humans, Kidney Neoplasms/drug therapy, Kidney Neoplasms/mortality, Male, Middle Aged, Phenylurea Compounds/administration & dosage, Phenylurea Compounds/adverse effects, Programmed Cell Death 1 Receptor/antagonists & inhibitors, Progression-Free Survival, Protein Kinase Inhibitors/therapeutic use, Quinolines/administration & dosage, Quinolines/adverse effects, Sunitinib/adverse effects, Sunitinib/therapeutic use, Survival Analysis, Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Renal Cell, Kidney Neoplasms, Medicine (all), General Medicine, Human health sciences, Oncology, Sciences de la santé humaine, Oncologie
العلاقة: http://www.nejm.org/doi/pdf/10.1056/NEJMoa2035716Test; urn:issn:0028-4793; urn:issn:1533-4406
الوصول الحر: https://orbi.uliege.be/handle/2268/300816Test
-
2دورية أكاديمية
المؤلفون: Choueiri, Toni K, Escudier, Bernard, Powles, Thomas, Mainwaring, Paul N, Rini, Brian I, Donskov, Frede, Hammers, Hans, Hutson, Thomas E, Lee, Jae-Lyun, Peltola, Katriina, Roth, Bruce J, Bjarnason, Georg A, Géczi, Lajos, Keam, Bhumsuk, Maroto, Pablo, Heng, Daniel Y C, Schmidinger, Manuela, Kantoff, Philip W, Borgman-Hagey, Anne, Hessel, Colin, Scheffold, Christian, Schwab, Gisela M, Tannir, Nizar M, Motzer, Robert J, Schöffski, Patrick
مصطلحات موضوعية: Adult, Aged, 80 and over, Anilides, Antineoplastic Agents, Carcinoma, Renal Cell, Disease-Free Survival, Everolimus, Female, Humans, Kidney Neoplasms, Male, Middle Aged, Pyridines, Quality of Life, Sirolimus, Survival Analysis
وصف الملف: 545699 bytes; application/pdf
العلاقة: New England Journal of Medicine vol:373 issue:19 pages:1814-23; https://lirias.kuleuven.be/handle/123456789/540820Test; https://lirias.kuleuven.be/bitstream/123456789/540820/1//Cabozantinib+versus+Everolimus+in+Advanced+Renal-Cell+Carcinoma.pdfTest
الإتاحة: https://lirias.kuleuven.be/handle/123456789/540820Test
https://lirias.kuleuven.be/bitstream/123456789/540820/1//Cabozantinib+versus+Everolimus+in+Advanced+Renal-Cell+Carcinoma.pdfTest -
3دورية أكاديمية
المؤلفون: Hutson, Thomas E., Davis, Ian D., Machiels, Jean-Pascal, De Souza, Paul L., Rottey, Sylvie, Hong, Bao-Fa, Epstein, Richard J, Baker, Katherine L, McCann, Lauren, Crofts, Theresa, Pandite, Lini, Figlin, Robert A
المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Unité d'oncologie médicale
المصدر: Journal of Clinical Oncology, Vol. 28, no. 3, p. 475-480 (2010)
مصطلحات موضوعية: Treatment Outcome, Sulfonamides, Pyrimidines, Middle Aged, Male, Kidney Neoplasms, Humans, Female, Carcinoma, Renal Cell, Antineoplastic Agents, Angiogenesis Inhibitors, Aged, 80 and over, Adult
العلاقة: boreal:28890; http://hdl.handle.net/2078.1/28890Test; info:pmid/20008644; urn:ISSN:0732-183X; urn:EISSN:1527-7755